NCT00131573
Completed
Phase 3
Battery Powered Bion Clinical Investigation: Bion - An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urgency-Frequency Syndrome
ConditionsOveractive Bladder
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Overactive Bladder
- Sponsor
- Boston Scientific Corporation
- Enrollment
- 118
- Locations
- 11
- Primary Endpoint
- Average Number of Voids Per Day
- Status
- Completed
- Last Updated
- 12 years ago
Overview
Brief Summary
The goal of this study is to investigate the safety and effectiveness of a new implanted device designed to treat Urinary Urgency-Frequency Syndrome.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Have any active implantable device regardless of whether stimulation status is ON or OFF.
- •Are pregnant as confirmed by a urine pregnancy test or plan to become pregnant during the following 12 month period.
- •Less than one year post partum and/or are breast-feeding.
- •Have any large passive implant that contains metal located within 30 cm of the chair pad while seated (e.g., hip replacement).
- •Have conditions requiring magnetic resonance imaging (MRI) evaluation.
- •Have conditions requiring diathermy procedures.
- •Have an inability to operate the bion Remote Control and bion Recharging System either by self or caregiver.
- •Have diabetes with peripheral nerve involvement or have severe uncontrolled diabetes.
- •Have history of coagulopathy or bleeding disorder.
- •Have pelvic pain in the absence of voiding dysfunction.
Outcomes
Primary Outcomes
Average Number of Voids Per Day
Time Frame: 12 months
Freedom From Major Complications
Time Frame: 5 years
Study Sites (11)
Loading locations...
Similar Trials
Completed
Phase 3
An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge IncontinenceUrinary IncontinenceNCT00080470Boston Scientific Corporation148
Completed
Phase 2
An Implantable Microneuromodulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke SubjectsShoulder Pain ChronicNCT00567541Bioness Inc16
Withdrawn
Phase 1
Implantable Microdevice for TNBC - Pilot StudyTriple Negative Breast CancerBreast Cancer Stage IIBreast Cancer Stage IIIBreast CancerEarly Stage Triple-Negative Breast CarcinomaBreast NeoplasmsBreast CarcinomaNCT05774886Dana-Farber Cancer Institute
Completed
Not Applicable
BRight DCB First-in-Human StudyPeripheral Artery DiseaseNCT04525794Biotronik CRC Inc.48
Terminated
Phase 2
Study of Occipital Nerve Stimulation for Drug Refractory MigraineMigraineNCT00747812Boston Scientific Corporation11